All the viral predictions of Pfizer’s accounts thanks to vaccines
Pfizer raised its annual revenue and profit forecasts. It now expects a turnover of between 78 billion and 80 billion dollars for the whole of 2021, compared to an estimated 70.5 and 72.5 billion in May, supported by sales of anti-Covid vaccines.
Pfizer toasts for economic results that look rosy also thanks to the Covid pandemic.
Here are all the details
WHAT PFIZER PROVIDES
The American pharmaceutical company Pfizer plans to sell anti-Covid vaccines developed in collaboration with Germany's BioNTech for a value of $ 33.5 billion this year, thanks to orders for 2.1 billion doses worldwide. A much higher figure than the $ 26 billion the group said it was targeting in May. Pfizer also revised up the outlook for annual sales and profits.
THE WORDS OF BOURLA
"The speed and effectiveness of our efforts with BioNTech to help vaccinate the world against Covid-19 is unprecedented, with more than a billion doses administered globally," said Group CEO Albert Bourla .
HOW SALES WILL GROW
Sales could grow further, as Pfizer / BioNTech claim a third dose of the serum makes it more effective, at a time when the Delta variant is causing epidemics in Asia and Africa and increasing the number of cases in Europe and states. United.
THE ROLE OF THE VARIANT
The variant, which initially appeared in India, is the most contagious since the onset of the pandemic in early 2020.
THE SCENARIOS ACCORDING TO PFIZER AND BIONTECH
The two companies reported in early July that the results of the third dose trials are "encouraging" and plan to seek authorization for release in the US and Europe.
ESTIMATES ON TURNOVER
On the strength of its growing sales, the company raised its annual revenue and profit forecasts. It now expects a turnover of between 78 billion and 80 billion dollars for the whole of 2021, against the 70.5 and 72.5 billion estimated in May, supported by sales of anti-Covid vaccines, which they have already collected 11.3 billion dollars in the first six months of the year.
EARNINGS FORECASTS
Earnings per share, which serves as a benchmark on Wall Street, could for its part grow from $ 3.95 to $ 4.05, against the initially expected move from 3.55 to 3.65.
HOW IS THE SECOND QUARTER GOING
In the second quarter alone, the group achieved a turnover of 18.9 billion dollars, almost double that of a year ago (+ 92%) and above the expectations of analysts, who counted on 18.45 billion. The quarterly net profit increased by 59% to 5.5 billion dollars.
This is a machine translation from Italian language of a post published on Start Magazine at the URL https://www.startmag.it/economia/tutte-le-previsioni-virali-dei-conti-di-pfizer-grazie-ai-vaccini/ on Wed, 28 Jul 2021 12:13:40 +0000.